1-2 of 2
Thierry Christophe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases

Luc Van Rompaey, René Galien, Ellen M. van der Aar, Philippe Clement-Lacroix, Luc Nelles, Bart Smets, Liên Lepescheux, Thierry Christophe, Katja Conrath, Nick Vandeghinste, Béatrice Vayssiere, Steve De Vos, Stephen Fletcher, Reginald Brys, Gerben van ’t Klooster, Jean H. M. Feyen, Christel Menet
Journal: The Journal of Immunology
J Immunol (2013) 191 (7): 3568–3577.
https://doi.org/10.4049/jimmunol.1201348
Published: 01 October 2013
View article titled, Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
Open the PDF for Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Isolation and Characterization of a Variant HL60 Cell Line Defective in the Activation of the NADPH Oxidase by Phorbol Myristate Acetate

Marianne Tardif, Marie-Josèphe Rabiet, Thierry Christophe, Marie-Danielle Milcent, François Boulay
Journal: The Journal of Immunology
J Immunol (1998) 161 (12): 6885–6895.
https://doi.org/10.4049/jimmunol.161.12.6885
Published: 15 December 1998
View article titled, Isolation and Characterization of a Variant HL60 Cell Line Defective in the Activation of the NADPH Oxidase by Phorbol Myristate Acetate
Open the PDF for Isolation and Characterization of a Variant HL60 Cell Line Defective in the Activation of the NADPH Oxidase by Phorbol Myristate Acetate in another window
Add to Citation Manager